Updates are available Correction dated 2026-06-27
Click to view Correction: https://doi.org/10.1007/s00204-026-04463-3
-
Authors
Henderson, C. J. https://orcid.org/0000-0002-4764-639X
McLaren, A. W.
MacLeod, A. K.
Lin, D.
Cameron, A. R.
Chatham, L. R.
Moggs, J.
Inesta-Vaquera, F.
Thomson, John P.
Meehan, Richard R.
Chakravarty, P.
Schwarz, M.
Wolf, C. Roland https://orcid.org/0000-0002-6969-0113
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (115001)
Cancer Research UK (C4639/A10822)
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 5 February 2025
First Online: 5 March 2025
Change Date: 27 June 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00204-026-04463-3
Declarations
:
: J. Moggs was a full-time employee of Novartis when the work presented in this paper was carried out.
: All animal work was carried out under the authority of the UK (Animal (Scientific Procedures) Act (1986), and EU Directive 2010/63, following approval by the Welfare and Ethical use of Animals Committee, University of Dundee. The University of Dundee is a signatory to the Concordat on Openness in Animal Research in the UK ( ).
